These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2649149)
1. Slow-release artificial tear inserts in the treatment of dry eyes in patients with rheumatoid arthritis. Hill JC Br J Ophthalmol; 1989 Feb; 73(2):151-4. PubMed ID: 2649149 [TBL] [Abstract][Full Text] [Related]
2. Effect of osmolarity of artificial tear drops on relief of dry eye symptoms: BJ6 and beyond. Wright P; Cooper M; Gilvarry AM Br J Ophthalmol; 1987 Feb; 71(2):161-4. PubMed ID: 3548809 [TBL] [Abstract][Full Text] [Related]
3. Slow-release artificial tears and the treatment of keratitis sicca. Katz JI; Kaufman HE; Breslin C; Katz IM Ophthalmology; 1978 Aug; 85(8):787-93. PubMed ID: 714379 [TBL] [Abstract][Full Text] [Related]
4. A clinical study of slow-releasing artificial tears. Lamberts DW; Langston DP; Chu W Ophthalmology; 1978 Aug; 85(8):794-800. PubMed ID: 714380 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of a severe course of keratoconjunctivitis sicca with eledoisin]. Jaeger W Klin Monbl Augenheilkd; 1988 Feb; 192(2):163-6. PubMed ID: 3283426 [TBL] [Abstract][Full Text] [Related]
6. Clinical trial of sustained-release artificial tears in keratoconjunctivitis sicca and Sjögren's syndrome. Lindahl G; Calissendorff B; Carle B Acta Ophthalmol (Copenh); 1988 Feb; 66(1):9-14. PubMed ID: 3284276 [TBL] [Abstract][Full Text] [Related]
7. Treatment of keratoconjunctivitis sicca with Lacrisert. Prause JU Scand J Rheumatol Suppl; 1986; 61():261-3. PubMed ID: 3296154 [TBL] [Abstract][Full Text] [Related]
8. Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca. Nelson JD; Farris RL Arch Ophthalmol; 1988 Apr; 106(4):484-7. PubMed ID: 2451494 [TBL] [Abstract][Full Text] [Related]
9. Sodium hyaluronate in the treatment of keratoconjunctivitis sicca. A double masked clinical trial. Sand BB; Marner K; Norn MS Acta Ophthalmol (Copenh); 1989 Apr; 67(2):181-3. PubMed ID: 2658462 [TBL] [Abstract][Full Text] [Related]
10. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients. Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211 [TBL] [Abstract][Full Text] [Related]
11. Topical application of hyaluronic acid and chondroitin sulfate in the treatment of dry eyes. Limberg MB; McCaa C; Kissling GE; Kaufman HE Am J Ophthalmol; 1987 Feb; 103(2):194-7. PubMed ID: 3101502 [TBL] [Abstract][Full Text] [Related]
19. Conjunctival surface damage distribution in keratoconjunctivitis sicca. An impression cytology study. Rolando M; Terragna F; Giordano G; Calabria G Ophthalmologica; 1990; 200(4):170-6. PubMed ID: 2367078 [TBL] [Abstract][Full Text] [Related]
20. The use of slow-release artificial tears in the long-term management of keratitis sicca. Werblin TP; Rheinstrom SD; Kaufman HE Ophthalmology; 1981 Jan; 88(1):78-81. PubMed ID: 7243230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]